Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic

NCT06805773 | Recruiting

• 1 other identifier: 4693
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment. Participants will watch four educational videos before their first appointment with a medical oncologist. Participants will be asked to complete surveys to assess their understanding of sarcoma and its treatment options before and after their first medical oncology clinic appointment.

Conditions

Sarcoma

Keywords

Education; Sarcoma

Outcome Measures

Primary Outcomes (1)

• Assess differences in patients' and caregivers' knowledge and perceptions of sarcoma and its treatment before and after educational intervention

  Evaluate the changes in global responses between baseline surveys and post educational intervention surveys.

  up to 2 weeks (date when given appointment and date of first appointment)

Secondary Outcomes (3)

• Assess understandability and actionability of sarcoma educational videos.

  up to 2 weeks (date when given appointment and date of first appointment)

• Assess understandability and actionability of sarcoma educational videos.

  up to 2 weeks (date when given appointment and date of first appointment)

• Assess patient's and caregivers' satisfaction with the educational videos

  up to 2 weeks (date when given appointment and date of first appointment)

Study Arms (2)

Educational Videos

EXPERIMENTAL

Other: Educational videos

Standard of Care

OTHER

Other: Standard of Care

Interventions

Educational videos OTHER

Participants will be provided with four educational videos in clinic prior to their initial medical oncology consult.

Educational Videos

Standard of Care OTHER

Participants in the control arm will be provided with the educational videos after their consult with the medical oncologist.

Standard of Care

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Signed written and voluntary informed consent.
• Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma.
• Age ≥ 18 years.
• Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma.
• Willing/able to complete questionnaires.
• Able to read and write in English.

You may not qualify if:

• Inability to provide informed consent.
• Previously seen by a medical oncologist for their sarcoma.

Sponsors & Collaborators

• Mount Sinai Hospital, Canada: lead

Study Sites (1)

Mount Sinai Hospital

Toronto, Ontario, M5G 1X5, Canada

RECRUITING

MeSH Terms

Conditions

Sarcoma

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health Care; Quality of Health Care; Health Services Administration; Health Care Quality, Access, and Evaluation

Central Study Contacts

Clinical Trials Manager

CONTACT

416-586-8440; Oncology.Research@sinaihealth.ca

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 23, 2025
• First Posted: February 3, 2025
• Study Start: May 5, 2025
• Primary Completion: April 1, 2026
• Study Completion: April 1, 2026
• Last Updated: September 25, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will share

Locations

CA (1)